0000899243-19-010587.txt : 20190412 0000899243-19-010587.hdr.sgml : 20190412 20190412160029 ACCESSION NUMBER: 0000899243-19-010587 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190411 FILED AS OF DATE: 20190412 DATE AS OF CHANGE: 20190412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amello Jason CENTRAL INDEX KEY: 0001451805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 19746282 MAIL ADDRESS: STREET 1: 500 KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 01824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-11 0 0001517022 Akebia Therapeutics, Inc. AKBA 0001451805 Amello Jason C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 0 1 0 0 SVP, CFO & Treasurer Common Stock 2019-04-11 4 D 0 13148 7.70 D 118618 D The proceeds from the disposition of these shares are to be used by the reporting person to cover tax liabilities associated with previously vested restricted stock units. /s/ John P. Butler, Attorney-in-fact for Jason A. Amello 2019-04-12